drugset / Trial / NCT00475917
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine a safe dose of XL844 in combination with gemcitabine, how often it should be taken, and how well people with cancer tolerate the combination of gemcitabine and XL844.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XL844 | Unknown | 5 mg | — |
| Subject | XL844 | Unknown | 25 mg | — |
| Subject | XL844 | Unknown | 100 mg | — |
| Background | Gemcitabine | Small molecule | — | Intravenous |